News from specialised therapeutics australia A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 05, 2019, 08:00 ET New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients

Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with...


Sep 18, 2015, 06:00 ET Specialised Therapeutics' Breakthrough Brain Tumour Visualisation Drug GLIOLAN(R) Approved for Use in New Zealand

A NOVEL drug which helps neurosurgeons to better visualise and remove malignant brain tumours has been approved for marketing and distribution in New ...


Aug 20, 2015, 07:02 ET STA: License Agreement with PharmaMar to Market, Distribute Oncology Drug APLIDIN(R) (plitidepsin) in AU and NZ

Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreement with European ...


May 08, 2015, 06:00 ET TGA Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) and Helsinn, a Swiss group focused on building quality cancer care,...


Oct 31, 2014, 08:00 ET Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer

Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce ABRAXANE® (nanoparticle albumin-bound...


Apr 28, 2014, 07:00 ET Specialised Therapeutics Australia To License New Drug - Iluvien(R) - To Improve Vision in Patients With Diabetes-induced Vision Loss

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new...